Drug Guide
Fexofenadine Hydrochloride
Classification
Therapeutic: Antihistamine for allergy relief
Pharmacological: Second-generation H1 antihistamine
FDA Approved Indications
- Relief of seasonal allergic rhinitis symptoms (hay fever)
- Relief of chronic idiopathic urticaria (hives)
Mechanism of Action
Fexofenadine antagonizes peripheral H1 histamine receptors, reducing allergy symptoms without significant sedative effects.
Dosage and Administration
Adult: 60 mg twice daily or 180 mg once daily
Pediatric: 30 mg twice daily for children 2-11 years; 60 mg twice daily for children 12 years and older
Geriatric: No specific dose adjustment necessary; start with lowest dose if renal impairment present
Renal Impairment: Reduce dose in moderate to severe renal impairment (creatinine clearance ≤ 60 mL/min)
Hepatic Impairment: No specific dose adjustment required
Pharmacokinetics
Absorption: Rapidly absorbed, peak plasma levels in 1-3 hours
Distribution: Low volume of distribution; approximately 60% bound to plasma proteins
Metabolism: Limited hepatic metabolism; mainly excreted unchanged
Excretion: Primarily in feces (70%) and urine (20%)
Half Life: 14 hours
Contraindications
- Hypersensitivity to fexofenadine or other ingredients
Precautions
- Use with caution in renal impairment; pregnancy category C; lactation considerations
Adverse Reactions - Common
- Headache (Common)
- Nausea (Common)
- Drowsiness (Less common)
Adverse Reactions - Serious
- Anaphylaxis (Rare)
- Hepatic impairment (Rare)
Drug-Drug Interactions
- May decrease absorption with Al or Mg containing products (antacids)
Drug-Food Interactions
- Avoid taking with fruit juices (grapefruit, apple, or orange juice) within 1 hour of dose, as they reduce absorption.
Drug-Herb Interactions
N/ANursing Implications
Assessment: Monitor for relief of allergy symptoms and adverse reactions.
Diagnoses:
- Impaired skin integrity related to allergic reaction
- Risk for side effects related to medication use
Implementation: Administer as directed; educate patient on timing and interactions.
Evaluation: Assess symptom relief and monitor for adverse effects.
Patient/Family Teaching
- Take with water; avoid fruit juices around time of dosing.
- Report any signs of allergic reactions or side effects.
- Do not exceed recommended dose.
Special Considerations
Black Box Warnings:
- None
Genetic Factors: None specified
Lab Test Interference: No known interference with lab tests
Overdose Management
Signs/Symptoms: Drowsiness, dizziness, dry mouth, headache, nausea
Treatment: Supportive care; activated charcoal if ingestion recent; symptomatic treatment as needed.
Storage and Handling
Storage: Store at room temperature, 20-25°C (68-77°F).
Stability: Stable until expiration date.